Startup profile · funding coverage
Talkiatry funding, valuation and investors
In-network telepsychiatry platform for value-based behavioral health.
Keep track of Talkiatry
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series C
$130M · June 2024
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$205M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · New York, NY
Investors in latest funding
Lead: Andreessen Horowitz
Overview
Talkiatry is a national mental health practice providing in-network psychiatry and therapy through telehealth. Co-founded in 2020 by a patient and triple-board-certified psychiatrist, the company built technology and operations to make psychiatrists in-network while delivering outcomes-based care for health plans. In June 2024, Talkiatry announced $130 million in equity and debt financing led by Andreessen Horowitz, with Perceptive Advisors and Banc of California debt participation — bringing total funding to $245 million. The company reports over one million patient visits and partnerships with expanding payer networks.
Why Talkiatry is interesting
Talkiatry proved psychiatric care can run in risk-based payer contracts — a16z-led $130M Series C after cutting hospitalizations 68% for a national health plan.
Product & use cases
Talkiatry delivers virtual psychiatry and therapy covered by major insurers, with operational tooling that lets psychiatrists stay in-network and health plans adopt risk-based behavioral health arrangements.
- Adults seeking in-network psychiatric care via telehealth
- Health plans reducing ER visits and hospitalizations through managed psychiatry
- Employers offering covered mental health access beyond EAP checkboxes
Key facts
- Series C (Jun 2024): $130M led by a16z; $245M total raised (PR Newswire)
- Named Fierce 15 in 2024; 1M+ patient visits reported
- Value-based outcomes: 68% hospitalization reduction cited for national health plan
- Co-founded by patient and psychiatrist to fix access and reimbursement gaps
Funding history (newest first)
Series C
2024-06 $130MSeries B
2023-09 $75MInvestors in our directory
Funds linked from Talkiatry's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Dual-sided model aligning psychiatrist reimbursement with payer value-based contracts — rare operational depth in telepsychiatry at scale.
Telepsychiatry is crowded post-COVID, but Talkiatry's payer outcomes data — 68% hospitalization reduction cited for one national plan — supports value-based pricing. Scale requires psychiatrist supply and payer contracting velocity.
-
Headway direct
Therapist/psychiatrist in-network matching; overlapping payer partnerships.
-
Lyra Health adjacent
Employer-sponsored mental health benefit; less psychiatry-first.
-
Traditional in-person psychiatry incumbent
Long wait times; many providers out-of-network.
Notable stories
- Talkiatry's Series C pitch centered on saving $700 per member per month versus peers for a leading national health plan — moving psychiatry from fee-for-service telehealth to contracted outcomes (PR Newswire, Jun 2024).
Industries
Related funding articles
Venture Capital Tracker pieces that cover Talkiatry's financing or category context.
FAQs about Talkiatry
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.